Synaptogenix Inc (SNPX)

[Cyosol]

Here's what I got from it:

- They have not received the data yet
- Dr. Alkon anticipates topline data will be out either the 1st or 2nd week of December
- They have $29M in cash and expect to raise another $20M after topline data
- They expect to run the P3 trial with their own money
- Dr. Alkon seems open to both an acquisition and partnership, but would prefer a partnership
- FXS and MS trials to commence in H1 2023
- No mention of a bioequivalence trial

Other than that, it was mostly more of the same. Personally, I think Dr. Alkon did a great job with the presentation.